Cezmi Akdis

Last updated

Cezmi Akdis is a medical researcher in the field of immunology. He is director of the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, Switzerland and the editor in chief of the journal Allergy .

Contents

He has been a professor in University of Zürich Medical Faculty since 2006, and one of the directors of the Christine Kühne-Center for Allergy Research and Education in Davos, Switzerland.

Education

Akdis Received his medical degree from Uludag University Medical Faculty, Bursa, Turkey in 1985. He has specialized in infectious disease and clinical microbiology 1991 and in immunology at Uludag University in 1994, and further was named a Venia Legendi (Habilitation) at the University of Zürich 2001. [1]

Publications

Akdis has published more than 650 articles. [2] His current h-index is 140. [2] and he has received over 80,000 [2] citations. He has also been selected to the ISI Web of Science and has received the Thomson Reuters (Clarivate) Highly Cited Researcher in the field of immunology in 2017, 2018, 2019, 2020 and 2021. [3]

Academic history

Contributions

Honors

References

  1. 1 2 3 4 "Cezmi Akdis Short Biography" (PDF). SIAF. Retrieved 21 February 2020.
  2. 1 2 3 "Google Scholar". scholar.google.com. Retrieved 2025-07-25.
  3. ↑ "Thomson Reuters Highly Cited Researcher" . Retrieved 21 February 2020.
  4. ↑ "Senate". SAMWASSM. Retrieved 13 May 2022.
  5. ↑ "Allergy Editorial Board". Wiley Online Library. doi:10.1111/(ISSN)1398-9995 . Retrieved 21 February 2020.
  6. ↑ Akdis, Cezmi (1996). "Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro". Journal of Clinical Investigation. 98 (7): 1676–83. doi:10.1172/JCI118963. PMC   507602 . PMID   8833918.
  7. ↑ Akdis, Cezmi (1998). "Role of interleukin 10 in specific immunotherapy". Journal of Clinical Investigation. 102 (1): 98–106. doi:10.1172/JCI2250. PMC   509070 . PMID   9649562.
  8. ↑ Jutel (2001). "Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors". Nature. 413 (6854): 420–5. Bibcode:2001Natur.413..420J. doi:10.1038/35096564. PMID   11574888.
  9. ↑ Trautmann (2000). "T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis". Journal of Clinical Investigation. 106 (1): 25–35. doi:10.1172/JCI9199. PMC   517909 . PMID   10880045.
  10. ↑ Deniz (2002). "Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells". European Journal of Immunology. 32 (3): 879–84. doi:10.1002/1521-4141(200203)32:3<879::AID-IMMU879>3.0.CO;2-2. PMID   11870632.
  11. ↑ Truatmann (2002). "T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma". Journal of Allergy and Clinical Immunology. 109 (2): 329–37. doi: 10.1067/mai.2002.121460 . PMID   11842305.
  12. ↑ Basinski (2009). "Dual nature of T cell-epithelium interaction in chronic rhinosinusitis". Journal of Allergy and Clinical Immunology. 124 (1): 74–80.e1–8. doi:10.1016/j.jaci.2009.04.019. PMID   19523671.
  13. ↑ Deniz (2008). "Regulatory NK cells suppress antigen-specific T cell responses". Journal of Immunology. 180 (2): 850–7. doi: 10.4049/jimmunol.180.2.850 . PMID   18178824.
  14. ↑ Agache (2012). "Untangling asthma phenotypes and endotypes". Allergy. 67 (7): 835–46. doi: 10.1111/j.1398-9995.2012.02832.x . PMID   22594878.
  15. ↑ Lötvall (2011). "Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome". Journal of Allergy and Clinical Immunology. 127 (2): 355–60. doi:10.1016/j.jaci.2010.11.037. PMID   21281866.
  16. ↑ Akdis, Cezmi (2013). "Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology". Journal of Allergy and Clinical Immunology. 131 (6): 1479–90. doi:10.1016/j.jaci.2013.02.036. PMC   4161279 . PMID   23587334.
  17. ↑ Akdis (2022). "The epithelial barrier hypothesis proposes a comprehensive understanding of the origins of allergic and other chronic noncommunicable diseases". Journal of Allergy and Clinical Immunology. 149 (1): 41–44. doi:10.1016/j.jaci.2021.11.010. PMID   34822880.
  18. ↑ Celebi Sozener (2022). "Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease" (PDF). Allergy. 75 (5): 1418–1449. doi: 10.1111/all.15240 . PMID   35108405.
  19. ↑ Wang (2019). "Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells". Journal of Allergy and Clinical Immunology. 143 (5): 1892–1903. doi: 10.1016/j.jaci.2018.11.016 . PMID   30500342.
  20. ↑ Basinski. "Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells". Journal of Allergy and Clinical Immunology. PMID   19523671.
  21. ↑ Sugita (2018). "Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients". Journal of Allergy and Clinical Immunology. 141 (1): 300–310.e11. doi: 10.1016/j.jaci.2017.02.038 . PMID   28392332.
  22. ↑ Xian (2016). "Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes". Journal of Allergy and Clinical Immunology. 138 (3): 890–893.e9. doi: 10.1016/j.jaci.2016.07.003 . PMID   27596709.
  23. ↑ Wawrzyniak (2017). "Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients" (PDF). Journal of Allergy and Clinical Immunology. 139 (1): 93–103. doi: 10.1016/j.jaci.2016.03.050 . PMID   27312821.
  24. ↑ Kubo (2015). "CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier". Journal of Allergy and Clinical Immunology. 136 (5): 1413–6.e1–8. doi: 10.1016/j.jaci.2015.05.006 . PMID   26100085.
  25. ↑ Soyka (2012). "Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4". Journal of Allergy and Clinical Immunology. 130 (5): 1087–1096.e10. doi: 10.1016/j.jaci.2012.05.052 . PMID   22840853.
  26. ↑ Sugita (2019). "Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL-13". Allergy. 74 (12): 2534–2537. doi:10.1111/all.13935. PMID   31166013.
  27. ↑ Kostaras, Charalampos. "EAACI Awards Winners 2016 | EAACI.org". www.eaaci.org. Archived from the original on 2020-02-29. Retrieved 2025-07-25.
  28. ↑ "Curriculum vitae Akdis, Cezmi A. Prof. Dr. med" (PDF). 18. Uludağ İç Hastalıkları Ulusal Kış Kongresi. Retrieved 10 May 2022.
  29. ↑ "Prof. Dr. Cezmi Akdis vom SIAF ist Träger des Erich Fuchs-Preises" (PDF). Academia Raetica. Retrieved 11 May 2022.
  30. ↑ "BUÜ Tıp Fakültesi'nden akademisyen çifte fahri profesörlük". Bursa Uludağ Üniversitesi Tıp Fakültesi. Retrieved 12 May 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.